These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 33021428)

  • 21. Visual MRI T-category versus VI-RADS evaluation from multiparametric MRI in the detection of muscle-invasion in patients with suspected bladder cancer: single centre registered clinical trial (MIB-trial).
    Nikulainen I; Salminen AP; Jambor I; Merisaari H; Tammilehto V; Taimen P; Seikkula H; Boström PJ
    Scand J Urol; 2021 Oct; 55(5):354-360. PubMed ID: 34448679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS.
    Kong L; Wen Z; Cai Q; Lin Y; Chen Y; Cao W; Li M; Qian L; Chen J; Guo Y; Wang H
    Acad Radiol; 2024 Feb; 31(2):564-571. PubMed ID: 37821347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the value of the VI-RADS scoring system in assessing muscle infiltration by bladder cancer.
    Wang Z; Shang Y; Luan T; Duan Y; Wang J; Wang H; Hao J
    Cancer Imaging; 2020 Apr; 20(1):26. PubMed ID: 32252816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) for the detection of muscle-invasive bladder cancer: a meta-analysis.
    Feng Y; Zhong K; Chen R; Zhou W
    Abdom Radiol (NY); 2022 Apr; 47(4):1396-1405. PubMed ID: 35181798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Additional MRI-Based Morphologic Measurements on the Performance of VI-RADS for Muscle-Invasive Bladder Cancer.
    Gong Y; Cheng Y; Zhang J; Bao ML; Zhu FP; Sun XY; Zhang YD
    J Magn Reson Imaging; 2024 Sep; 60(3):1113-1123. PubMed ID: 38258496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of actual stage prediction using Vesical Imaging Reporting and Data System (VI-RADS) before radical cystectomy for urothelial carcinoma in SUPER-UC-Cx.
    Kim SH; Han JH; Jeong SH; Yuk HD; Jeong CW; Kwak C; Kim HH; Kim SY; Kim TM; Cho JY; Ku JH
    Transl Androl Urol; 2023 Feb; 12(2):168-175. PubMed ID: 36915877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a fractional-order calculus diffusion model and bi-parametric VI-RADS for staging and grading bladder urothelial carcinoma.
    Feng C; Wang Y; Dan G; Zhong Z; Karaman MM; Li Z; Hu D; Zhou XJ
    Eur Radiol; 2022 Feb; 32(2):890-900. PubMed ID: 34342693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VI-RADS: Multiinstitutional Multireader Diagnostic Accuracy and Interobserver Agreement Study.
    Ueno Y; Tamada T; Takeuchi M; Sofue K; Takahashi S; Kamishima Y; Urase Y; Kido A; Hinata N; Harada K; Fujisawa M; Miyaji Y; Murakami T
    AJR Am J Roentgenol; 2021 May; 216(5):1257-1266. PubMed ID: 32755215
    [No Abstract]   [Full Text] [Related]  

  • 29. Preliminary Exploration of the Application of Vesical Imaging-Reporting and Data System (VI-RADS) in Post-treatment Patients With Bladder Cancer: A Prospective Single-Center Study.
    Cao B; Li Q; Xu P; Chen W; Hu X; Dai C; Shan Y; Ding Y; Mao W; Liu K; Wu PY; Sun W; Rao S; Zeng M; Jiang S; Zhou J
    J Magn Reson Imaging; 2022 Jan; 55(1):275-286. PubMed ID: 34184337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy and reliability of VI-RADS in determining candidates for repeated transurethral resection in patients with high-risk non-muscle invasive bladder cancer.
    Erkoc M; Otunctemur A; Bozkurt M; Can O; Atalay HA; Besiroglu H; Danis E; Degirmentepe RB
    Int J Clin Pract; 2021 Sep; 75(9):e14584. PubMed ID: 34185372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiparametric MRI Evaluation of VI-RADS for Bladder Tumors Located at the Ureteral Orifice.
    Cai Q; Ling J; Kong L; Huang Y; Lin Y; Wen Z; Li M; Guo Y; Wang H
    Radiology; 2022 Sep; 304(3):593-599. PubMed ID: 35670714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic performance of multiparametric MRI based Vesical Imaging-Reporting and Data System (VI-RADS) scoring in discriminating between non-muscle invasive and muscle invasive bladder cancer.
    Islam NU; Jehangir M; Parry AH; Nazir SS; Bilal S
    Pol J Radiol; 2023; 88():e356-e364. PubMed ID: 37701172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective assessment of VI-RADS score in multiparametric MRI in bladder cancer: accuracy and the factors affecting the results.
    Oğuz U; Bekçi T; Öğreden E; Aslan S; Duman A; Demirelli E; Şengül D; Tok DS; Çiftçi OÇ; Tosun A
    Diagn Interv Radiol; 2022 Sep; 28(5):396-402. PubMed ID: 35997477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Vesical Imaging-Reporting and Data System (VI-RADS) scoring system in predicting muscle invasion of bladder cancer.
    Liu S; Xu F; Xu T; Yan Y; Yao X; Tang G
    Transl Androl Urol; 2020 Apr; 9(2):445-451. PubMed ID: 32420150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology.
    Arita Y; Yoshida S; Shigeta K; Kwee TC; Edo H; Okawara N; Hashimoto M; Ishii R; Ueda R; Mikami S; Fujiwara M; Waseda Y; Kikuchi E; Fujii Y; Jinzaki M
    Eur Urol Oncol; 2023 Feb; 6(1):99-102. PubMed ID: 35933266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is high accuracy of Vesical Imaging-Reporting and Data System (VI-RADS) sufficient for its implementation in the urological practice?
    Rysankova K; Hanzlikova P; Zidlik V; Vrtkova A; Slisarenko M; Skarda J; Grepl M; Krhut J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Mar; 167(1):85-90. PubMed ID: 36628563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative Prediction of Muscle Invasiveness in Bladder Cancer: The Role of 3D Volumetric Radiomics Using Diffusion-Weighted MRI, the VI-RADS Score, or a Combination of Both.
    Şam Özdemir M; Azamat S; Özdemir H; Keskin ET; Savun M; Şimşek A; Yardımcı AH
    Ann Surg Oncol; 2024 Sep; 31(9):5845-5850. PubMed ID: 39003377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of VI-RADS in predicting muscle-invasive bladder cancer after transurethral resection: a single center retrospective analysis.
    Chai JL; Roller LA; Liu X; Lan Z; Mossanen M; Silverman SG; Shinagare AB
    Abdom Radiol (NY); 2024 May; 49(5):1593-1602. PubMed ID: 38502214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Vesical Imaging-Reporting and Data System (VI-RADS) for detecting the muscle invasion of bladder cancer: a diagnostic meta-analysis.
    Luo C; Huang B; Wu Y; Chen J; Chen L
    Eur Radiol; 2020 Aug; 30(8):4606-4614. PubMed ID: 32242273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proposal for a New Vesical Imaging-Reporting and Data System (VI-RADS)-Based Algorithm for the Management of Bladder Cancer: A Paradigm Shift From the Current Transurethral Resection of Bladder Tumor (TURBT)-Dependent Practice.
    Taguchi S; Watanabe M; Tambo M; Machida H; Yokoyama K; Fukuhara H
    Clin Genitourin Cancer; 2022 Aug; 20(4):e291-e295. PubMed ID: 35346591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.